Yuanbao Inc.(YB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

YB Yuanbao Inc.

Pre-Mkt 08-31 08:55:19 EDT

13.49

-0.22

-1.60%

High13.90	Low13.46	Vol16.03K
Open13.71	D1 Closing13.71	Amplitude3.21%
Mkt Cap621.62M	Tradable Cap110.62M	Total Shares46.08M
T/O218.78K	T/O Rate0.20%	Tradable Shares8.20M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"YB","market":"US","secType":"STK","nameCN":"Yuanbao Inc.","latestPrice":13.49,"timestamp":1787947200000,"preClose":13.71,"halted":0,"volume":16029,"delay":0,"changeRate":-0.016046681254558763,"floatShares":8200500,"shares":46080200,"eps":4.19,"marketStatus":"Pre-Mkt","change":-0.22,"latestTime":"08-31 08:55:19 EDT","open":13.7105,"high":13.9,"low":13.46,"amount":218778,"amplitude":0.032093,"askPrice":15.19,"askSize":100,"bidPrice":13.25,"bidSize":801,"shortable":3,"etf":0,"ttmEps":4.19,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788183000000},"marketStatusCode":1,"adr":0,"adrRate":6,"listingDate":1745985600000,"exchange":"NASDAQ","adjPreClose":13.49,"dividendRate":0.093403,"postHourTrading":{"tag":"盘后","latestPrice":13.49,"preClose":13.49,"latestTime":"16:10 EDT","volume":2,"amount":26.98,"timestamp":1787947805170,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.488466664937969},"requestUrl":"/m/hq/s/YB/tweets","defaultTab":"tweets","newsList":[{"id":"2662065979","title":"YB Ventures Malaysia 4th-Quarter 2026 Earnings Summary Table","url":"https://stock-news.laohu8.com/highlight/detail?id=2662065979","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662065979?lang=en_us&edition=fundamental","pubTime":"2026-08-28 17:36","pubTimestamp":1787909760,"startTime":"0","endTime":"0","summary":"Figures Are In Ringgit (MYR).Revenue                      13,593,000         15,677,000. PreTax Profit                -3,827,000        -44,830,000. Net Profit                   -7,699,000        -46,955,000. Earnings Per Share            -2.63 Sen         -16.09 Sen. Dividend                       0.00 Sen           0.00 Sen. Revenue                      50,258,000         64,868,000. PreTax Profit               -28,163,000        -63,178,000. Net Profit                  -32,087,000        -65,364,000. Earnings Per Share           -10.98 Sen         -22.39 Sen. Dividend                       0.00 Sen           0.00 Sen","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659733155","title":"Press Release: Yarrow Bioscience Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659733155","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659733155?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:00","pubTimestamp":1786618800,"startTime":"0","endTime":"0","summary":"--  The Company initiated the Phase 2a/2b trial of YB-101 in patients with. Graves' disease , with or without concurrent thyroid eye disease. --  The Phase 2a portion of the trial is a randomized,four cohorts designed to evaluate safety, pharmacokinetics ,pharmacodynamics , and efficacy over 24 weeks, including the. percentage of patients who are euthyroid and off anti-thyroid. drugs, as well as relevant measures of orbitopathy in patients. --  Topline results from the Phase 2a portion of the trial are. --  The Phase 2b portion of the trial is expected to commence in the. --  Licensing partner, Changchun GeneScience Pharmaceutical Co., Ltd.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WDGF","BK4007","YB","FOWF","LU1169589451.USD","GD","BK4588","IDEF","PK","LU0170899867.USD","BK4550","PD","BK4173","PPA","KBWY","BK4181","SHLD","BK4218","BK4516","BK4023","YARW","BK4187","TSHR","BK4566","BK4585","LU1169590202.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654188596","title":"Yarrow Bioscience initiated with a Buy at TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2654188596","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654188596?lang=en_us&edition=fundamental","pubTime":"2026-07-28 23:05","pubTimestamp":1785251123,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Stacy Ku initiated coverage of Yarrow Bioscience (YARW) with a Buy rating. YB-101 is the leading anti-thyroid stimulating hormone ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/yarrow-bioscience-initiated-with-a-buy-at-td-cowen-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/yarrow-bioscience-initiated-with-a-buy-at-td-cowen-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4207","GSIB","YB","TD","BK4173","COWN","BK4585","BK4127","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172460343","title":"Yarrow Bioscience Finalizes Merger with VYNE, Starts Phase 2 Trial for Graves' Disease Drug YB-101","url":"https://stock-news.laohu8.com/highlight/detail?id=1172460343","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172460343?lang=en_us&edition=fundamental","pubTime":"2026-07-27 22:01","pubTimestamp":1785160880,"startTime":"0","endTime":"0","summary":"Clinical-stage biotechnology company Yarrow Bioscience announced today that it has completed its merger with VYNE Therapeutics, simultaneously closing a roughly $200 million private placement...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YARW","VYNE","BK4007","YB","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654043338","title":"Yarrow Bioscience Completes VYNE Therapeutics Merger, Begins Phase 2 Trial Dosing for YB-101","url":"https://stock-news.laohu8.com/highlight/detail?id=2654043338","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654043338?lang=en_us&edition=fundamental","pubTime":"2026-07-27 21:17","pubTimestamp":1785158242,"startTime":"0","endTime":"0","summary":"Yarrow Bioscience  said Monday that it has completed its merger with VYNE Therapeutics and the previously announced private financings totaling approximately $200 million.The combined company will operate as Yarrow Bioscience and its shares are expected to begin trading on the Nasdaq Capital Market on Tuesday under the ticker symbol YARW.The combined company will be led by President and Chief Executive Officer Rebecca Frey, Chief Operating Officer Rachael Alford, and Chief Financial Officer Tyler Zeronda.Bill Lundberg, former chief executive of biotech firm Merus, will become chairman of the board of directors.Yarrow said its lead product candidate, YB-101, is a potential first-in-class anti-thyroid-stimulating hormone receptor monoclonal antibody designed to directly disrupt the central mechanism driving both Graves' disease and thyroid eye disease in a single targeted treatment.The company also said it has initiated dosing in a Phase 2a/2b trial of YB-101 in patients with Graves' dis","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["YARW","YB","BK4007","BK4173","VYNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654145380","title":"Press Release: Yarrow Bioscience Announces Closing of Merger with VYNE Therapeutics and Initiation of Dosing in Phase 2a/2b Trial of Yb-101, a Potential First-in-Class Treatment for Graves' Disease and Thyroid Eye Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2654145380","media":"Dow Jones","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654145380?lang=en_us&edition=fundamental","pubTime":"2026-07-27 19:00","pubTimestamp":1785150000,"startTime":"0","endTime":"0","summary":"Yarrow is advancing YB-101--a potential first-in-class anti-TSHR antibody, designed to directly disrupt the central mechanism driving both Graves' disease (\"GD\") and thyroid eye disease (\"TED\")Dosing ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4173","YARW","YB","BK4007","VYNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648562430","title":"Stocks Ex-dividend July 2","url":"https://stock-news.laohu8.com/highlight/detail?id=2648562430","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648562430?lang=en_us&edition=fundamental","pubTime":"2026-07-01 04:56","pubTimestamp":1782852960,"startTime":"0","endTime":"0","summary":"Gl Net Lease Pfd. A           GNLpA        8.0     0.45313. Glbl Net Lease Pfd D          GNLpD        8.1     0.46875. Global Net Lease Pfd E        GNLpE        8.1     0.46094. Global Net Lease Pfd. B       GNLpB        8.0     0.42969. Source: FactSet Dow Jones NewswiresJune 30, 2026 16:56 ET Copyright  2026 Dow Jones & Company, Inc.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YB","VIG","BK4588","BK4585","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642585258","title":"Yuanbao, Inc. Earnings Call Highlights AI-Powered Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2642585258","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642585258?lang=en_us&edition=fundamental","pubTime":"2026-06-12 08:12","pubTimestamp":1781223149,"startTime":"0","endTime":"0","summary":"Yuanbao, Inc. Unsponsored ADR (($YB)) has held its Q1 earnings call. Read on for the main highlights of the call. Yuanbao, Inc. Unsponsored ADR del...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/yuanbao-inc-earnings-call-highlights-ai-powered-surge?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/yuanbao-inc-earnings-call-highlights-ai-powered-surge?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CHAT","AIPO","YB","ARTY","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642423455","title":"Yuanbao Inc. Posts Strong Q1 2026 Results and Deepens AI Push in Online Insurance","url":"https://stock-news.laohu8.com/highlight/detail?id=2642423455","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642423455?lang=en_us&edition=fundamental","pubTime":"2026-06-10 19:39","pubTimestamp":1781091572,"startTime":"0","endTime":"0","summary":"The latest update is out from Yuanbao, Inc. Unsponsored ADR ( ($YB) ). Yuanbao Inc., a Chinese technology-driven online insurance distributor, repo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/yuanbao-inc-posts-strong-q1-2026-results-and-deepens-ai-push-in-online-insurance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/yuanbao-inc-posts-strong-q1-2026-results-and-deepens-ai-push-in-online-insurance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["YB","CHAT","ARTY","AIPO","BK4173","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642045447","title":"Yuanbao to remain focused  on high-quality revenue growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2642045447","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642045447?lang=en_us&edition=fundamental","pubTime":"2026-06-10 18:17","pubTimestamp":1781086651,"startTime":"0","endTime":"0","summary":"Ray Wan, CFO of Yuanbao (YB), said, “In the Q1, we delivered another strong performance, driven by our continued business expansion and operating e...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/yuanbao-to-remain-focused-on-high-quality-revenue-growth-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/yuanbao-to-remain-focused-on-high-quality-revenue-growth-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["YB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642244770","title":"Yuanbao announces $15M share repurchase program","url":"https://stock-news.laohu8.com/highlight/detail?id=2642244770","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642244770?lang=en_us&edition=fundamental","pubTime":"2026-06-10 18:16","pubTimestamp":1781086589,"startTime":"0","endTime":"0","summary":"The Company announced that its Board of Directors has authorized a share repurchase program under which the Company may repurchase up to $15M of it...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/yuanbao-announces-15m-share-repurchase-program-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/yuanbao-announces-15m-share-repurchase-program-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4173","YB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642022447","title":"Yuanbao reports Q1 EPS RMB 8.02 vs. RMB 6.46 last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2642022447","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642022447?lang=en_us&edition=fundamental","pubTime":"2026-06-10 18:10","pubTimestamp":1781086237,"startTime":"0","endTime":"0","summary":"Reports Q1 revenue RMB 1.315B vs. RMB 970.06M last year. Rui Fang, Chairman and CEO of Yuanbao (YB), commented, “As the insurance industry enters a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/yuanbao-reports-q1-eps-rmb-8-02-vs-rmb-6-46-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/yuanbao-reports-q1-eps-rmb-8-02-vs-rmb-6-46-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["YB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642473454","title":"Yuanbao Q1 Adj. EPS $1.23 Up From $0.94 YoY, Sales $190.760M Up From $133.677M YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2642473454","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642473454?lang=en_us&edition=fundamental","pubTime":"2026-06-10 18:01","pubTimestamp":1781085706,"startTime":"0","endTime":"0","summary":"Yuanbao (NASDAQ:YB) reported quarterly earnings of $1.23 per share. This is a 30.85 percent increase over earnings of $0.94 per share from the same period last year.  The company reported $190.760 million in sales this","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/06/53109011/yuanbao-q1-adj-eps-1-23-up-from-0-94-yoy-sales-190-760m-up-from-133-677m-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642473334","title":"Yuanbao Q1 FY26 net income rises 31.4% to RMB 387.6 million; revenue increases 35.6% to RMB 1.32 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2642473334","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642473334?lang=en_us&edition=fundamental","pubTime":"2026-06-10 18:00","pubTimestamp":1781085645,"startTime":"0","endTime":"0","summary":"Yuanbao posted Q1 2026 revenue of RMB 1.32 billion, up 35.6% year over year.Net income rose 31.4% from a year earlier to RMB 387.6 million; net margin narrowed 0.9 percentage points to 29.5%.Operating cash inflow totaled RMB 721.3 million; cash and equivalents plus deposits and investments climbed 71.4% year over year to RMB 4.74 billion.Insurance distribution services revenue increased 27.8% to RMB 411.3 million; system services revenue grew 39.8% to RMB 904.6 million.Board set an annual cash dividend of USD 1.26 per ADS, authorizing a USD 15 million ADS repurchase program.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nNDL1Wynqj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","IE00BN0W2W23.USD","BK4173","BK4112","SG9999014039.USD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","SG9999014005.SGD","LU2095319765.USD","SG9999014013.SGD","LU2210150020.SGD","YB","SG9999014021.USD","IE00BKPKM429.USD","LU0314104364.USD","IE00BGHQF748.EUR","NDAQ","BK4585","BK4588","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642447388","title":"Yuanbao Inc. Announces First Quarter 2026 Unaudited Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2642447388","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642447388?lang=en_us&edition=fundamental","pubTime":"2026-06-10 18:00","pubTimestamp":1781085602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nTUA9NBK8H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4173","YB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642447312","title":"Yuanbao - Q1 Total Revenues up 35.6% to $190.8 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2642447312","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642447312?lang=en_us&edition=fundamental","pubTime":"2026-06-10 18:00","pubTimestamp":1781085602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nTUA9NBK8H:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["YB","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642447308","title":"Yuanbao Inc - Q1 Net Income per Ads $1.16","url":"https://stock-news.laohu8.com/highlight/detail?id=2642447308","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642447308?lang=en_us&edition=fundamental","pubTime":"2026-06-10 18:00","pubTimestamp":1781085602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nTUA9NBK8H:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["YB","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641128412","title":"3 High‑Quality Undiscovered Gems With Standout ROE And Margins","url":"https://stock-news.laohu8.com/highlight/detail?id=2641128412","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641128412?lang=en_us&edition=fundamental","pubTime":"2026-06-06 05:35","pubTimestamp":1780695304,"startTime":"0","endTime":"0","summary":"With inflation pressures tied to energy and freight, shifting central bank policies, and uneven growth across regions, many investors are looking beyond the usual large cap stocks. That is where the High-Quality Undiscovered Gems screener comes in. It focuses on smaller companies with solid fundamentals that are less crowded by big funds. By targeting stocks that are not heavily owned by institutions, you are not just following the usual playbook; you are looking where others are not paying...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/1022000-choice2-main-header/1585186558401","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/1022000-choice2-main-header/1585186558401"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/energy/nyse-oii/oceaneering-international/news/3-highquality-undiscovered-gems-with-standout-roe-and-margin","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/energy/nyse-oii/oceaneering-international/news/3-highquality-undiscovered-gems-with-standout-roe-and-margin","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XZO","YB","BK4173","ROE","OII","BK4107","BK4179"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640377903","title":"Yuanbao updates financial calendar with Q1 results release, earnings call planned","url":"https://stock-news.laohu8.com/highlight/detail?id=2640377903","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640377903?lang=en_us&edition=fundamental","pubTime":"2026-06-03 18:00","pubTimestamp":1780480858,"startTime":"0","endTime":"0","summary":"Yuanbao to release Q1 2026 unaudited financial results on June 10, 2026, before the US market open.Management earnings call set for June 10, 2026 at 8:00 a.m. ET.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL2f4K30:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","LU0314104364.USD","IE00BKPKM429.USD","IE00BN0W2V16.EUR","LU2210149790.SGD","IE00B64PRP62.GBP","LU2210150020.SGD","YB","SG9999014005.SGD","LU2095319765.USD","SG9999014021.USD","IE00BGHQF748.EUR","NDAQ","IE00BN0W2W23.USD","BK4173","IE00BN0W2T93.GBP","BK4585","BK4588","IE00B3QW5Z07.USD","SG9999014039.USD","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640903443","title":"Yuanbao Inc. to Announce First Quarter 2026 Financial Results on Wednesday, June 10, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640903443","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640903443?lang=en_us&edition=fundamental","pubTime":"2026-06-03 18:00","pubTimestamp":1780480800,"startTime":"0","endTime":"0","summary":"BEIJING, June  03, 2026  (GLOBE NEWSWIRE) -- Yuanbao Inc. (“Yuanbao” or the “Company”) (NASDAQ: YB), a leading technology-driven online insurance distributor in China, today announced that it will rel","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/03/3305856/0/en/Yuanbao-Inc-to-Announce-First-Quarter-2026-Financial-Results-on-Wednesday-June-10-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YB","BK4173"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.yuanbaobaoxian.cn","stockEarnings":[{"period":"1week","weight":-0.0022},{"period":"1month","weight":0.0045},{"period":"3month","weight":-0.0916},{"period":"6month","weight":-0.3096},{"period":"1year","weight":-0.4212},{"period":"ytd","weight":-0.3342}],"compareEarnings":[{"period":"1week","weight":0.0047},{"period":"1month","weight":0.0547},{"period":"3month","weight":0.017},{"period":"6month","weight":0.1215},{"period":"1year","weight":0.1856},{"period":"ytd","weight":0.1282}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Yuanbao, Inc. operates as a holding company, which provides online insurance distribution and services. Its products include million medical insurance, comprehensive accident insurance, and major disease insurance. The company was founded by Rui Fang in December 2019 and is headquartered in Beijing, China.","exchange":"NASDAQ","name":"Yuanbao Inc.","nameEN":"Yuanbao Inc.","securityTypeName":"DR","adrRate":"1:6"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.48.0","shortVersion":"4.48.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Yuanbao Inc.(YB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Yuanbao Inc.(YB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Yuanbao Inc.,YB,Yuanbao Inc.股票,Yuanbao Inc.股票老虎,Yuanbao Inc.股票老虎国际,Yuanbao Inc.行情,Yuanbao Inc.股票行情,Yuanbao Inc.股价,Yuanbao Inc.股市,Yuanbao Inc.股票价格,Yuanbao Inc.股票交易,Yuanbao Inc.股票购买,Yuanbao Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Yuanbao Inc.(YB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Yuanbao Inc.(YB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction